| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/07/2005 | WO2005061013A1 Personal care products with visual indicator of vaginitis |
| 07/07/2005 | WO2005061002A2 Composition and methods for modulating cns activity |
| 07/07/2005 | WO2005060725A2 Nucleic acid amplification methods |
| 07/07/2005 | WO2005060721A2 Manipulation of rna interference through modulation of armitage activity |
| 07/07/2005 | WO2005060675A2 Novel spliced 5-ht1a receptors and methods, kits, and uses relating thereto |
| 07/07/2005 | WO2005060661A2 Methods and materials for assessing prostate cancer therapies |
| 07/07/2005 | WO2005060656A2 Identification of a gene expression profile that differentiates ischemic and nonischemic cardiomyopathy |
| 07/07/2005 | WO2005060641A2 Engineered templates and their use in single primer amplification |
| 07/07/2005 | WO2005060626A2 Metal ion mediated fluorescence superquenching assays, kits and reagents |
| 07/07/2005 | WO2005060618A2 Enzyme-free isothermal exponential amplification of nucleic acids and nucleic acid analog signals |
| 07/07/2005 | WO2005060542A2 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 07/07/2005 | WO2005060541A2 Peptides and methods for inducing cellular resistance to infection |
| 07/07/2005 | WO2005060517A2 Genes commonly regulated by different classes of antidepressants |
| 07/07/2005 | WO2005060375A2 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 07/07/2005 | WO2005060345A2 New method for sequencing-by-synthesis |
| 07/07/2005 | WO2005060344A2 Direct identification and mapping of rna transcripts |
| 07/07/2005 | WO2005047538A3 Ligands of the mycobacterial repressor ethr, selection methods, and applications |
| 07/07/2005 | WO2005043162A8 Method for distinguishing mll-ptd-positive aml from other aml subtypes |
| 07/07/2005 | WO2005042770A3 Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria |
| 07/07/2005 | WO2005038043A3 Methods of detecting poly (adp-ribose) polymerase and other nad+utilizing enzymes |
| 07/07/2005 | WO2005035556A3 Sars-coronavirus virus-like particles and methods of use |
| 07/07/2005 | WO2005033333A3 Methods and compositions for the diagnosis of cancer |
| 07/07/2005 | WO2005030269A8 Endotoxin-nonresponsive model animal |
| 07/07/2005 | WO2005027719A3 Methods and systems for identifying predisposition to the placebo effect |
| 07/07/2005 | WO2005026205A3 Genetic products which are differentially expressed in tumours and use thereof |
| 07/07/2005 | WO2005024380A9 Method and system for assaying transferase activity |
| 07/07/2005 | WO2005024064A3 A detection method for autism and related disorders |
| 07/07/2005 | WO2005021741A3 Diagnostics and therapeutics for diseases associated with kallikrein 11 (klk11) |
| 07/07/2005 | WO2005021025A3 MODULATION OF β-CATENIN/TCF ACTIVATED TRANSCRIPTION |
| 07/07/2005 | WO2005020785A3 Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis |
| 07/07/2005 | WO2005019419A3 Co-detection of single polypeptide and polynucleotide molecules |
| 07/07/2005 | WO2005016966A3 Intron fusion proteins, and methods of identifying and using same |
| 07/07/2005 | WO2005006971A3 Method for assessing behavioral predisposition |
| 07/07/2005 | WO2005003821A3 Phase change sensor |
| 07/07/2005 | WO2005003293A3 pRNA CHIMERA |
| 07/07/2005 | WO2005001138A3 Breast cancer survival and recurrence |
| 07/07/2005 | WO2004113567A9 Improved heavymethyl assay for the methylation analysis of the gstpi gene |
| 07/07/2005 | WO2004111612A3 Porous nanostructures and methods involving the same |
| 07/07/2005 | WO2004099364A3 Multicellular compositions of pluripotent human embryonic stem cells and cancer cells |
| 07/07/2005 | WO2004096020A3 Method for detection and characterization of pre-malignant transformation |
| 07/07/2005 | WO2004092340A3 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 07/07/2005 | WO2004089810A3 Microfluidic devices and methods of using same |
| 07/07/2005 | WO2004084830A3 Method for treating alzheimer’s dementia |
| 07/07/2005 | WO2004080425A3 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 07/07/2005 | WO2004072296A3 Compositions for modulating immune cell activity and methods for detection thereof |
| 07/07/2005 | WO2004062570A3 Apparatus and method to measure platelet contractility |
| 07/07/2005 | WO2004052290A3 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 07/07/2005 | WO2004044586A8 Nanotube-based electronic detection of biological molecules |
| 07/07/2005 | WO2004042032A3 Cytogenetic abnormalities that are predictive of response to therapy for chronic lymphocytic leukemia |
| 07/07/2005 | WO2004026265A9 Compositions and methods for treatment of herpesvirus infections |
| 07/07/2005 | WO2004024892A8 Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis |
| 07/07/2005 | WO2004003233A8 Methods to assess quality of microarrays |
| 07/07/2005 | WO2003103593A3 Secretases related to alzheimer's dementia |
| 07/07/2005 | WO2003089583A3 Tissue specific genes and gene clusters |
| 07/07/2005 | US20050149994 Rapidly maturing fluorescent proteins and methods for using the same |
| 07/07/2005 | US20050149272 Method for sequencing polynucleotides |
| 07/07/2005 | US20050148772 Methods and compositions for detecting polynucleotide duplex damage and errors |
| 07/07/2005 | US20050148761 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 07/07/2005 | US20050148613 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/07/2005 | US20050148537 Immunostimulatory nucleic acid molecules |
| 07/07/2005 | US20050148532 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types |
| 07/07/2005 | US20050148531 Antisense agents; blocking agents (biotin); high throughput screening |
| 07/07/2005 | US20050148527 Catalytic nucleic acids; ribozymes; translation inhibition; gene expression inhibition; for treating cardiovascular disease; for neovascularization induction in heart tissue |
| 07/07/2005 | US20050148526 Methods of obtaining isoform specific expression in mammalian cells |
| 07/07/2005 | US20050148515 Peptidomimetics; determining ability to bind growth hormone secretagogue; ghrelin agonists; appetite stimulation; dietetics |
| 07/07/2005 | US20050148514 Method and composition for treatment of angiogenesis |
| 07/07/2005 | US20050148509 Insulin-like growth factor; fusion proteins; chimera; apoptosis |
| 07/07/2005 | US20050148506 Novel method of modulating bone-related activity |
| 07/07/2005 | US20050148505 Genes and agents to regulate follicular development, ovulation cycle and steriodogenesis |
| 07/07/2005 | US20050148502 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43 |
| 07/07/2005 | US20050148494 Methods and compositions for controlling appetite and modulating insulin sensitivity |
| 07/07/2005 | US20050148101 Immobilized colloid particles; automatic determination of changes in colloids using electromagnetic radiation or absorption |
| 07/07/2005 | US20050148100 Methods and devices for using Raman-active probe constructs to assay biological samples |
| 07/07/2005 | US20050148087 Isobarically labeled analytes and fragment ions derived therefrom |
| 07/07/2005 | US20050148075 With binding specificity for target nucleotides containing one or GNN triplets; regulating gene expression |
| 07/07/2005 | US20050148072 Human liver progenitors |
| 07/07/2005 | US20050148062 Transgenic microorganisms comprising apoptosis associated genes for use as tools in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/07/2005 | US20050148045 Using transgenic microorganism comprising gene coding fostriecin polyketide synthase to generates antitumor antibiotics; bioreactors; anticarcinogenic agents |
| 07/07/2005 | US20050148044 Nutrient broth comprising a metal complex and an indoxyl derivative for use in colorimetric detection of microorganisms |
| 07/07/2005 | US20050148043 Such as adenosine; comprises platinum or platinum alloy, layer comprising a sugar-derivative of a pyrrole, second layer comprising an amphiphilic pyrrole, and xanthine oxidase; kits |
| 07/07/2005 | US20050148042 Hybrid phosphoinositide phospholipids: compositions and uses |
| 07/07/2005 | US20050148034 Using reduced microvessel outgrowth of pluripotent stem cells as diagnostic indicator angoigenseis inhibition; antitumor agents |
| 07/07/2005 | US20050148033 Testing and confirming donor and recipient blood types at the point of transfusion; blood transfusion and typing; quality control and point of care health |
| 07/07/2005 | US20050148031 Using membrane traversing peptide conjugate comprising reporter element to transfer fluorescent molecules across cell membranes |
| 07/07/2005 | US20050148029 Using presence of inflammation marker to diagnose and prognose systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) |
| 07/07/2005 | US20050148027 Very large scale immobilized polymer synthesis |
| 07/07/2005 | US20050148025 Differential diagnosis with hepcidin |
| 07/07/2005 | US20050148020 ATM kinase compositions and methods |
| 07/07/2005 | US20050148018 Methods of identifying inverse agonists of the serotonin 2A receptor |
| 07/07/2005 | US20050148017 Antisense oligonucleotides against tenascin for the treating of vitiligo |
| 07/07/2005 | US20050148015 Nucleic acid fragments for the identification of dechlorinating bacteria |
| 07/07/2005 | US20050148014 Regulation of human P2Y1-like G protein-coupled receptor |
| 07/07/2005 | US20050148013 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/07/2005 | US20050148012 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 07/07/2005 | US20050148011 Mixture comprising nucleic acid-modifying enzyme for use in chromatographic or electrophoretic analysis |
| 07/07/2005 | US20050148010 Tracer reagents that enhance reaction-product analysis |
| 07/07/2005 | US20050148009 Tracer reagents that enhance reaction-product analysis |
| 07/07/2005 | US20050148007 Using yeast culture system comprising deletion and bioluminescent markers as tool in screening test agents; carcinogen testing |
| 07/07/2005 | US20050148005 Dye solubilization binding assay |
| 07/07/2005 | US20050148004 Chemical arrays and methods of using the same |